by Samsara@8529 | Jan 5, 2022 | Home, News
News Article Samsara Therapeutics Establishes Scientific Advisory Board Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics Oxford, UK and Boston, US, 06 January... 